To check if higher expression/activity of TRAP in humans with pulmonary disease was a general phenomenon that could be extrapolated to mouse models, we examined TRAP activity in lungs of mice exposed to either cigarette smoke for 9 months (COPD model) or house dust mite (HDM) for 2 weeks (asthma model). This evidence concerns the gene ACP5 and lung disorder.